Company / CapEx per Share
KalVista Pharmaceuticals, Inc. CapEx per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.01
FY2025
5-year range
$0.00 / $0.05
FY2021-FY2025
Trend
+16.8%
vs FY2024
Sector context
#124 of 192
Health Care
What the data says
At $0.01, KalVista Pharmaceuticals, Inc.'s capex per share ranks #124 of 192 in the Health Care sector. CapEx per Share has fluctuated over the past 10 years, ranging from $0.00 in FY2018 to $0.14 in FY2017.
Based on SEC 10-K filings.
0.01 in FY2025 with a 5-year CAGR of +16.5%.
Improved from $0.00 to $0.01 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -40.7%
- 5-Year CAGR
- +16.5%
- 10-Year CAGR
- -
Sector benchmark
#124 of 192 in Health CareTop 65% of 192This company $0.01 Sector average $2.46
▼
-99.6% below sector average
Key checks
Key Insights
- In FY2025, capex per share increased 16.8% year-over-year.
- Ranks #124 out of 192 companies in the Health Care sector.
- Peak capex per share was recorded in FY2017.
- Lowest capex per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -3.72 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.01 | +16.8% |
| FY2024 | $0.01 | +665.6% |
| FY2023 | $0.00 | -97.7% |
| FY2022 | $0.05 | -6.1% |
| FY2021 | $0.05 | +999.2% |
| FY2020 | $0.00 | -30.7% |
| FY2019 | $0.01 | +505.0% |
| FY2018 | $0.00 | -99.2% |
| FY2017 | $0.14 | +768.1% |
| FY2016 | $0.02 | -96.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026